• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

MiMedx Group (MDXG)

Common Shares
Sell: $6.63|Buy: $6.80|Change: 0.04 (-0.58%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISA

Company profile

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Address

1775 West Oak Commons Court NE
Marietta
GA
USA
30062

Telephone

+1 770 6519383

Website

https://www.mimedx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
MiMedx Group Inc First Quarter Earnings Conference Call for 20262026-04-30T16:30:00
MiMedx Group Inc First Quarter Earnings Results for 20262026-04-30T00:00:00
MiMedx Group Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T16:30:00
MiMedx Group Inc Fourth Quarter Earnings Results for 20252026-02-26T00:00:00
MiMedx Group Inc Annual Report for 20252026-02-26T00:00:00
MiMedx Group Inc Third Quarter Earnings Conference Call for 20252025-10-30T16:30:00
MiMedx Group Inc Third Quarter Earnings Results for 20252025-10-30T00:00:00
MiMedx Group Inc Second Quarter Earnings Conference Call for 20252025-07-31T16:30:00
MiMedx Group Inc Second Quarter Earnings Results for 20252025-07-31T00:00:00
MiMedx Group Inc Annual General Meeting for 20252025-06-05T09:00:00

Previous key dates

NameKey Date
MiMedx Group Inc First Quarter Earnings Conference Call for 20252025-04-30T16:30:00
MiMedx Group Inc First Quarter Earnings Results for 20252025-04-30T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T11:10:00
MiMedx Group Inc Fourth Quarter Earnings Conference Call for 20242025-02-26T16:30:00
MiMedx Group Inc Fourth Quarter Earnings Result for 20242025-02-26T00:00:00
MiMedx Group Inc Annual Report for 20242025-02-26T00:00:00
15th Annual Craig-Hallum Alpha Select Conference2024-11-19T00:00:00
Stifel Healthcare Conference 20242024-11-18T09:45:00
MiMedx Group Inc Third Quarter Earnings Conference Call for 20242024-10-30T16:30:00
MiMedx Group Inc Third Quarter Earnings Result for 20242024-10-30T00:00:00
MiMedx Group will participate in the 2024 Cantor Global Healthcare Conference2024-09-18T08:00:00
MiMedx Group will participate in the Lake Street 8th Annual Big8 Best Ideas Growth Conference2024-09-12T00:00:00
MiMedx Group will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-06T00:00:00
MiMedx Group Inc Second Quarter Earnings Conference Call for 20242024-07-31T16:30:00
MiMedx Group Inc Second Quarter Earnings Result for 20242024-07-31T00:00:00
Northland Growth Conference 20242024-06-25T00:00:00
MiMedx Group Inc Annual General Meeting for 20242024-06-05T09:00:00
Craig-Hallum 21(st) Annual Institutional Investor Conference2024-05-29T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.